FDA inspections are evolving. Equip your clinical supply team to manage on-site and remote audits with confidence and turn findings into stronger systems.
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
- Transitioning Into A Clinical Trial Supply Chain Study Lead Role
- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
- Beyond The AI Hype: Prompt Engineering In Clinical Trial Supply
- Active Versus Passive Shipping Solutions For Clinical Shipments
- Managing Risk And Resilience In Clinical Trial Supply And Operations
- FDA Staffing Constraints And Operational Risk In Clinical Supply
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Risk Mitigation In Direct-To-Patient Clinical Trials
The DTP model can help alleviate risks in patient enrollment (including diversity), retention, and adherence to study timelines and budgets. Explore how to ease trial troubles through DTP.
-
A Custom IRT System Facilitates Precision Medicine Studies
As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
Revolutionizing Trial Supply Management With The Power Of Free Picking
Discover the power of SmartSignals RTSM’s new free picking feature, designed to revolutionize trial supply management by optimizing efficiency and reducing costs.
-
Overcoming Cell Therapy Supply Chain Challenges
For the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
-
Precision and Compliance in Pharmaceutical Packaging
Reliable, compliant packaging preserves product integrity, supports regulatory readiness, and lowers risk. Careful components and controlled processes keep complex therapies protected.
-
Overcoming Challenges In Cell And Gene Therapy Containment
Review the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Faster From Formulation To Fill/Finish
Optimize your speed to clinic by securing a development and aseptic fill/finish partner to support your applications with the right manufacturing equipment, communications, and SOPs.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
Risk Mitigation Planning For Pharmaceutical Tariffs
Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.